BAVENCIO (EMD Serono, Inc.)
Welcome to the PulseAid listing for the BAVENCIO drug offered from EMD Serono, Inc.. This Programmed Death Ligand-1 Blocker [EPC],Programmed Death Ligand-1 Antagonists [MoA],Programmed Death Ligand-1-directed Antibody Interactions [MoA],Antibodies, Monoclonal [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | EMD Serono, Inc. |
| NON-PROPRIETARY NAME: | avelumab |
| SUBSTANCE NAME: | AVELUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Programmed Death Ligand-1 Blocker [EPC],Programmed Death Ligand-1 Antagonists [MoA],Programmed Death Ligand-1-directed Antibody Interactions [MoA],Antibodies, Monoclonal [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2017-03-23 |
| END MARKETING DATE: | 0000-00-00 |
BAVENCIO HUMAN PRESCRIPTION DRUG Details:
| Item Description | BAVENCIO from EMD Serono, Inc. |
| LABELER NAME: | EMD Serono, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2017-03-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 44087-3535_181c2ecf-ab54-4b9e-b933-c80827083f5a |
| PRODUCT NDC: | 44087-3535 |
| APPLICATION NUMBER: | BLA761049 |
Other AVELUMAB Pharmaceutical Manufacturers / Labelers:
